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OBJECTIVE—To evaluate modiﬁcations of arterial structure,
gene expression, and function in our model of rats exposed to
maternal diabetes.
RESEARCH DESIGN AND METHODS—Morphometric analy-
ses of elastic vessels structure and determination of thoracic
aortic gene expression proﬁle with oligonucleotide chips (Agi-
lent, G4130, 22k) were performed before the onset of established
hypertension (3 months).
RESULTS—Arterial parameters of in situ ﬁxed thoracic aorta
were not signiﬁcantly different between control mother offspring
and diabetic mother offspring (DMO). The aortic gene expression
proﬁle of DMO is characterized by modiﬁcations of several
members of the arachidonic acid metabolism including a twofold
underexpression of prostacyclin receptor, which could contrib-
ute to decreased vasodilatation. This was conﬁrmed by ex vivo
experiments on isolated aortic rings. Pharmacological studies on
conscious rats showed that systolic blood pressure decline in
response to a PGI2 analog was impaired in DMO rats.
CONCLUSIONS—These results suggest an abnormal vascular
fetal programming of prostacyclin receptor in rats exposed in
utero to maternal hyperglycemia that is associated with impaired
vasodilatation and may be involved in the pathophysiology of
hypertension in this model. Diabetes 59:2597–2602, 2010
C
ardiovascular disease is one of the greatest
health burdens worldwide. Cardiovascular risk
is determined not only by conventional risk
factors in adult life but also by early life events
resulting in resetting of key physiological functions. Mod-
iﬁcations of the intrauterine environment during speciﬁc
windows of fetal development are now recognized as
important causes of fetal stress (1), leading to several
responses such as loss of structure/function and preemp-
tive adaptations to an adverse postnatal environment (2),
and ﬁnally to adult diseases such as metabolic abnormal-
ities and hypertension (1,3).
Nutrition is one of the major intrauterine environmental
factor that alters expression of the fetal genome and may
have lifelong consequences leading to limited physiologi-
cal function and disease (4,5). Particularly, the conse-
quences of maternal diabetes in the adult offspring are
gaining attention (6,7). Interestingly, both metabolic disor-
ders and raised blood pressure have increasingly been
associated with in utero exposure to maternal diabetes
(8).
Several animal models such as modiﬁcation of maternal
nutrition, reduction of uterine supply, or glucocorticoid
treatment have contributed to the understanding of some
of the mechanisms involved in fetal/perinatal program-
ming by showing that kidney changes and alterations of
hormones regulation are involved in the fetal program-
ming of hypertension (3,9,10). More recently, alterations of
vascular function in several models of fetal programming
also have been implied (11,12). In previous works (13,14),
we developed a rat streptozotocin-induced model of fetal
exposure to maternal diabetes, characterized by moderate
levels of maternal hyperglycemia, normal gestation, and
delivery with healthy pups without intrauterine growth
retardation. Diabetic mother offspring (DMO) presented
an established hypertension at 6 months of age (9). The
exact mechanism leading to late onset of hypertension in
this model is unknown. The present work was designed to
evaluate changes in vascular properties through genetic
proﬁle and pharmacological studies in DMO compared
with control mother offspring (CMO) at prehypertensive
stage.
RESEARCH DESIGN AND METHODS
Diabetes was induced in Sprague-Dawley rats (250–300 g) at day 0 of gestation
by using a single intraperitoneal injection of streptozotocin (Sigma, 35 mg/kg)
as previously described (9,13,14). The diabetic state was checked in fasted
rats by measuring the plasma glucose concentration (Accuchek, Roche) on
tail blood. Only pregnant females whose plasma glucose ranged between 15
and 20 mmol/l were included in the study. This diabetic status was conﬁrmed
every 2 days until delivery. On the day of delivery, the newborn rats were
weished. Each litter was then reduced to 10 pups. All the animals were house
kept at Centre d’Explorations Fonctionnelles. They were maintained in a
temperature- and light-controlled room at 21°C with a 12-h light cycle. They
had free access to food (SAFE Laboratory) and tap water. All experiments
were performed at 3 months of age corresponding to prehypertensive stage.
Six to seven different litters of CMO and DMO animals were used for the entire
study. Each experiment was performed on males obtained from a minimum of
three different litters. All experiments were conducted in accordance with the
institutional guidelines and the recommendations for the care and use of
laboratory animals put forward by the French Ministry of Agriculture.
Blood pressure measurements. Blood pressure measurements were per-
formed on CMO and DMO animals at 3 and 12 months of age, respectively, to
conﬁrm the development of hypertension. Rats were instrumented under
sodium pentobarbital anesthesia (60 mg/kg i.p.; Sanoﬁ) with an arterial
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diabetes.diabetesjournals.org DIABETES, VOL. 59, OCTOBER 2010 2597catheter (PE-50 fused to PE-10: internal diameter, –0.28 mm; outside diame-
ter, 0.61 mm) inserted via the femoral artery to record blood pressure. The
catheter was led subcutaneously to exit between the scapulae. Upon regaining
consciousness, animals were housed in individual cages. After 3 days of
recovery, blood pressure was recorded on conscious unrestrained animals
during 30 min. The arterial catheter was connected to a pressure transducer
(P10EZ, Becton Dickinson) linked with a Gould RS 3400 polygraph to measure
continuously pulsatile blood pressure.
Histomorphometry analysis. Morphological studies were performed on the
thoracic aorta of 3-month-old CMO and DMO animals. Arterial samples were
ﬁxed in 10% buffered formalin and embedded in parafﬁn. Sections (6 m) were
stained with orcein for elastic ﬁbers and sirius red for collagen to measure
internal and external media perimeters, intima-media thickness, medial cross-
sectional area, and elastic ﬁber and collagen densities of the media by
computer-directed color analysis (NIS-Elements AR2.3, Nikon). Brieﬂy, colla-
gen and elastin densities are the ratio of the areas of collagen and elastin
(stained with sirius red and orcein, respectively) detected and measured with
the camera and the program-driven computer on the area of the tissue in a
given microscopic ﬁeld.
Microarray analysis. Gene expression proﬁle was performed on thoracic
aorta in 3-month-old CMO and DMO animals.
RNA extraction of total RNA and preparation of cDNA. Total RNA was
extracted from thoracic aortic samples by TRIzol reagent (Invitrogen). The
quality and concentration were checked by the Agilent technology. Good-
quality RNA was ampliﬁed by the Amino Allyl MessageAmp aRNA kit (Applied
Biosystems), according to the manufacturer’s instructions. Ten samples (ﬁve
CMO and ﬁve DMO) were isolated with sufﬁcient yield and integrity for
complete microarray analysis.
Hybridization on microarrays. Transcript proﬁling was performed using rat
Agilent G4130A arrays. These microarrays contained 22,000 distinct oligo-
nucleotide probes (60 mers). The list of the 22,575 probes is available online
(http://www.chem.agilent.com). Antisense RNA was coupled with Cy3 and
Cy5 postlabeling reactive dyes (Amersham) by a reverse transcription step.
After a postprocessing step, microarrays were hybridized with labeled RNA as
previously described (15). Slides were scanned with a ScanArray 5000 (GSI
Lumonics), and images were quantiﬁed with the GenePix Pro 5.0 program
(Axon Instruments,). This technique offers the possibility to hybridize two
samples on the same slide: a control and a pathological sample. Values of
pathological samples were normalized to values of control samples to
compare pathological samples between them. Moreover, because incorpora-
tions of Cy3 and Cy5 dyes can differ signiﬁcantly, data were further normal-
ized using a dye-swap method (16); this method required duplication of
experiments. For that purpose, a ﬁrst microarray was hybridized with
pathological and control samples labeled with Cy3 and Cy5, respectively. A
second “swap” microarray was hybridized with pathological and control
samples labeled with inverted dyes. Statistical analysis was performed using
SAM software (Signiﬁcance Analysis of Microarray) as described in Fig. 1. The
microarray result has been deposited in the GEO database (http://www.ncbi.
nlm.nih.gov/geo/) under GEO Series Accession number GSE16750.
Conﬁrmation of modiﬁcations observed in arachidonic acid metabo-
lism. Reverse transcription from 2 g of total RNA was carried out to generate
cDNA. Real-time PCR was then performed for each cDNA preparation from
thoracic aorta of 3-month-old rats, using the Applied Biosystem together with
the SYBRGreen master mixture for prostacyclin receptor (IP) or with the
TaqMan technology for Cyp4f2. Expressions were normalized to the expres-
sion level of -actin.
Western blot analysis of proteins of interest was performed following
previously described techniques (17). Brieﬂy, proteins were extracted from
arterial biopsies of CMO and DMO. Total protein content was determined by
the Bradford technique (18), and equal amounts (50 g) of the denatured
proteins were used. Membranes were incubated with polyclonal antibodies
directed against IP and Cyp4f2. The detection was performed by chemilumi-
nescence emitted from luminol oxidized by peroxidase (ECL system,
Amersham).
Pharmacological studies. To validate functional effect of decrease in IP in
DMO, we studied the effect of an analog of prostacyclin (PGI2) on vascular
dilatory function in isolated thoracic aorta and on blood pressure in conscious
CMO and DMO animals at 3 months of age.
Ex vivo study. Vascular dilatory function was assessed in response to
beraprost (Cayman) in isolated thoracic aorta obtained from 7 CMO and 10
DMO animals. Arterial segments (2 mm long) were dissected and mounted on
a wire myograph (Danish MyoTechnology, DMT) as previously described (19).
Brieﬂy, two tungsten wires (25 m in diameter) were inserted into the lumen
of the arteries and ﬁxed to a force transducer and a micrometer, respectively.
Arteries were bathed in a 5-ml organ bath containing a physiological salt
solution maintained at a pH of 7.4, a pO2 of 160 mmHg, and a pCO2 of 37
mmHg. After wall-tension normalization, arteries were allowed to stabilize for
1 h. Endothelial integrity was assessed by evaluating the vasodilator effect of
10
6 mol/l acetylcholine (Sigma-Aldrich), after preconstriction treatment with
10
6 mol/l phenylephrine (Sigma-Aldrich). Cumulative concentration–re-
sponse curve to beraprost (0.001–30 mol/l) was performed after phenyleph-
rine-induced preconstriction (1 mol/l). Endothelium-independent relaxation
to sodium nitroprusside was obtained at the end of the protocol.
In vivo study. Eight CMO and six DMO animals were instrumented as
described above with a supplementary venous catheter inserted into the right
jugular vein to allow the injection of the pharmacological product, and the two
catheters were led subcutaneously to exit between the scapulae. Systolic
blood pressure (SBP) was extracted from the whole blood pressure signal,
and heart rate was calculated. Recordings were performed at rest during 30
min. The experiment started when cardiovascular parameters were stable.
The effect of another analog of PGI2, iloprost (Schering, i.v.), was determined
on arterial blood pressure and heart rate.
Statistical analysis. For microarray analysis, SAM (Stanford University, CA)
was applied to identify genes differentially expressed between DMO and CMO.
Brieﬂy, SAM computes a score for each gene that measures the strength of
transcript correlation with survival. This score (d) is the maximum-likelihood
score statistic from Cox’s proportional hazards model (Cox score). A thresh-
old value was chosen to give a reasonably low false-positive rate (10%), as
estimated by repeatedly permuting the survival times and counting the
number of genes that were signiﬁcant at each threshold. Missing data were
handled using the K-nearest neighbors imputer (k  10) of the SAM imputa-
tion engine.
For other experiments, all results are expressed as the mean  SEM.
Statistical analysis was performed by a nonparametric Mann-Whitney test or
by ANOVA when appropriate. Statistical signiﬁcance was deﬁned as P  0.05.
RESULTS
Development of hypertension. DMO and CMO animals
had similar SBP at 3 months of age (141.9  3.2 mmHg,
n  17, vs. 136.9  3.6 mmHg, n  16). SBP was
signiﬁcantly higher in DMO than in CMO animals at 12
months of age (166.9  8.4 mmHg, n  8, vs. 136.6  4.5
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FIG. 1. Analysis of proﬁling data. Scheme for analysis of proﬁling data
at 3 months of age (A) and demonstration of the robustness of
microarray technology with the swap method (B). Correlation between
Cy3 values and Cy5 values obtained with the corresponding swap slide
for the 22,575 transcripts. FDR, false discovery rate.
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DMO between 3 and 12 months of age (P  0.01).
Vascular structure. Table 1 shows that arterial parame-
ters of in situ ﬁxed thoracic aorta were not signiﬁcantly
different between CMO and DMO at 3 months of age.
Under light microscopy, orcein stain did not reveal mor-
phological changes of the elastic bundles in DMO com-
pared with CMO (data not shown).
Microarrays analysis. RNA samples of 3-month-old aorta
were analyzed. We isolated 119 genes differentially ex-
pressed between DMO and CMO (Fig. 1A); the full list of
these 119 genes is presented in supplementary Table 2,
available in an online appendix at http://diabetes.
diabetesjournals.org/cgi/content/full/db10-0311/DC1.
Transcriptome analysis is often criticized for a lack of
reproducibility of quantiﬁcation. However, the require-
ment of duplication of experiments (use of swap) has
improved this reproducibility of quantiﬁcation. The spe-
ciﬁc signal associated with a spot (representative of a
gene) was deﬁned by the geometrical average of the
speciﬁc intensities of this spot in direct and swapped
experiments. We found a very good correlation between
the intensity of a spot in direct experiment and that in
swapped experiment (Fig. 1B).
We classiﬁed the 119 transcripts differentially expressed
between groups, according to the seven functional cate-
gories described by Hwang et al. (20). As a group, tran-
scripts encoding proteins potentially involved in the
mechanical regulation of vascular function (“signaling/
communication” and “structure/motility”) constituted the
most important group with 35% of the annotated tran-
scripts (Fig. 2A). Examples of the former groups are genes
related to extracellular matrix, cytoskeleton, or cellular
junctions (Fig. 2B). Interestingly, most differentially ex-
pressed genes were implicated in the arachidonic acid
metabolism. Among these genes, IP (i.e., D28966) expres-
sion was strongly reduced (d  1.990, fold change 
0.5). Genes implicated in production of 20-hydroxyeicosa-
TABLE 1
Histomorphological parameters of the thoracic aorta in 3-month-
old CMO and DMO animals
Component/parameters CMO DMO
MCSA (mm
2  10
3) 483  22 461  11
IMT (m) 97.1  3.6 92.8  2.3
Internal perimeter (m) 4,921.1  134.0 4,835.0  44.8
External perimeter (m) 5,739.3  123.2 5,603.2  29.4
Elastin density (%) 22.3  0.06 20.0  0.10
Collagen density (%) 17.6  0.03 15.2  0.02
Data are means  SE. n  6. IMT, intima-media thickness; MCSA,
medial cross-sectional area.
Gene expression 
27% 
Cell communication 
23% 
Cell structure/ motility 
12% 
Cell / organism defense 
6% 
Metabolism 
8% 
Cell division 
3% 
Unclassified 
21% 
A 
B  Gene Description  fold-change 
Extracellular matrix 
TC519817 extensin-like  protein  3.5 
Fbln2 fibulin-2  2.9 
Gp2 glycoprotein  2  7.8 
Cytoskeleton 
Evl  enabled vasodilator stimulated phosphoprotein  0.5 
XM_238549  similar to cytoskeleton protein 49  0.4 
Dcamkl1  double cortin and calcium/calmodulin-dependent protein kinase-like 1  0.3 
Ckap4  cytoskeleton-associated protein 4  0.3 
Ril  reversion induced LIM gene  0.6 
Cellular junction 
Gjb1  gap junction membrane chanel protein beta 1  3.6 
Cdh1 cadherin  1  2.9 
TC539966  protocadherin beta 9  7.5 
Pdch18  protocadherin beta 18  2.4 
Metabolism of arachidonic acid 
Cyp4f4  cytochrome P450 family 4, subfamily f, polypeptide 4  2.6 
Cyp4f2  cytochrome P450 family 4, subfamily f, polypeptide 2  2.0 
D28966 prostacyclin  receptor  0.5 
score (d) 
1.879 
1.834 
1.712 
- 1.927 
-1.889 
-1.880 
-1.860 
-1.855 
2.069 
1.982 
1.806 
1.792 
1,874 
1.782 
-1.990 
FIG. 2. Microarray analysis. A: Classiﬁcation of the differentially expressed genes between DMO and CMO according to the seven functional
categories described by Hwang et al. (20) at 3 months of age. B: Genes of interest implicated in extracellular matrix, cytoskeleton, cellular
junctions, and metabolism of arachidonic acid (d  statistical score).
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Cyp4f4) were overexpressed (Fig. 2B). These genes have
the most signiﬁcant d value correlated to the better fold
change and are then considered as major targets. Modiﬁ-
cations induced by modulation of expression of these
genes involved in vascular biology could contribute to
hypertension development. Thus, the following study fo-
cused on IP and Cyp4f2.
RT-PCR and protein analysis. RT-PCR and Western blot
analysis were performed on CMO and DMO thoracic aorta
in another independent experimental set of rats to conﬁrm
the modulation of expression of IP and Cyp4f2 genes. A
signiﬁcant downregulation was detected in the IP gene in
DMO compared with CMO. Relative gene expression lev-
els were 0.46  0.22 in DMO and 1.10  0.24 in CMO
(respectively, n  7 and n  10, each from four different
litters, P  0.05, Fig. 3A). The decreased expression of IP
transcript was conﬁrmed at the protein level (n  5 from
three different litters, Fig. 3B), with an 2.5-fold decrease
in DMO compared with CMO (P  0.048), consistent with
the 0.5-fold underexpression of the corresponding gene
observed by microarray and RT-PCR. We did not detect
any signiﬁcant increase of Cyp4f2 at gene and protein
levels (data not shown).
Pharmacological studies. We examined whether the
decrease in IP protein level was associated with functional
modiﬁcations. Ex vivo experiments on isolated thoracic
aorta rings showed a signiﬁcantly decreased vasodilatory
function in DMO compared with CMO (Fig. 4, P  0.01) in
response to beraprost.
During in vivo experiments, we observed a blunted
decrease in SBP in response to 4 ng/kg/ml iloprost in DMO
(10.7%, from 139 to 124 mmHg) compared with CMO
(24.1%, from 134.4 to 105.8 mmHg, P  0.040, for
difference, Fig. 5), whereas SBP was identical at lower
dosage. Heart rate was similar in the two groups (377.0 
10.9 bpm in DMO vs. 371.5  12.6 bpm in CMO) at any
dose.
DISCUSSION
The major result of the present study is that exposure to
maternal diabetes is associated with profound changes in
aortic gene expression and function in the adult offspring.
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FIG. 5. Pharmacological studies. Dose-response curve to iloprost in
CMO (E) and DMO (F). Values are means  SEM. *P < 0.05 vs. CMO.
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the thoracic aorta in DMO rats, including genes related to
extracellular matrix, cytoskeleton, or cellular junctions
and arachidonic acid metabolism. We focused on mem-
bers of the arachidonic acid metabolism and found that IP
expression was reduced by 50% at the messenger and
protein levels in aorta of the DMO rats. Functional impli-
cation of IP downexpression was demonstrated in aortic
ring experiments with an impaired vasodilatation response
to PGI2 analog of vessels issued from DMO rats. Concur-
rently, in vivo experiments showed that PGI2 analog-
dependent effect on SBP was blunted in DMO.
Our experimental study showing a reduced vascular
expression of IP in animals exposed in utero to maternal
diabetes reinforces the evidence of a reprogramming of
vascular function by modiﬁcations of the intrauterine
environment. Indeed, vascular functions in the rat off-
spring have been recently investigated in models of im-
pairment of maternal diet during pregnancy, that is, high-
fat, hypocaloric, or low-protein diets. These studies have
evidenced a vascular dysfunction mainly related to im-
paired endothelial functions through the assessment of the
NO pathway (11,12,21,22). One must note that, in contrast
to our experimental protocol, several of these works were
conducted in established hypertension and thus did not
address early abnormalities of the vessel wall. Thus, it is
still unclear whether these abnormalities, that is, impaired
endothelium-dependent relaxation, occur ﬁrst or develop
as a consequence of hypertension. However, endothelial
dysfunction may occur without hypertension; Rodford et
al. (23) recently identiﬁed reduced endothelial responsive-
ness to acetylcholine, unexpected increased eNOS vascu-
lar expression, and systemic reduction of antioxidant
protection in a protein-restricted rat model with normal
blood pressure. Concerning exposure to maternal diabe-
tes, Rocha et al. (24) showed a decreased endothelium-
dependent vasodilatation in mesenteric arteries of 12-
month-old rats (after several months of hypertension)
issued from diabetic mothers.
Vascular fetal programming of PGI2/IP pathway has
never been reported until now. Because prostacyclin plays
a key role in several vascular functions, in particular in the
control of vascular tone by promoting vasodilatation and
differentiation of vascular smooth muscle cell (25), our
results raise the question of the consequences of an early
downexpression of vascular IP (3-month-old animals) in
view of the hypertension that will be established at 6
months in our model. First, prostacyclin analog was less
effective in reducing blood pressure in DMO rats as
compared with CMO. This indicates that IP downexpres-
sion is involved in the abnormal regulation of blood
pressure in DMO. Second, at the vascular level, although
vasodilatation properties of resistance arteries, that is,
mesenteric arteries, are not evaluated here, impaired
vasodilatation response to PGI2 analog is evidenced in
DMO aortic rings. Together, these results suggest that IP-
decreased expression may participate in abnormal regula-
tion of arterial pressure in DMO through impaired vasodi-
latation responses. Interestingly, vascular expression of
IP- has been studied in spontaneous hypertensive rats
(SHR). In this strain, Numaguchi et al. (26) showed a
diminished expression of IP mRNA in thoracic aorta
before the onset of hypertension (1 month of age). How-
ever, in established hypertension (9 months of age), Tang
and Vanhoutte (27) showed similar levels of IP transcripts
in vascular smooth muscle cells of SHR compared to
Wistar Kyoto. At a functional level, relaxation obtained in
aortic rings, in response to PGI2 or IP agonist, was
impaired in 3-month-old SHR and was further decreased in
older animals (28).
To conclude, our experimental study shows that expo-
sure to maternal diabetes is associated with a decreased IP
vascular expression in the adult offspring. Although it is
not currently known if fetal programming of IP may be
relevant in humans, a recent study on a natural mutation of
IP (R212C variant, defective in adenyl cyclase activation)
has shown that impaired PGI2 signaling appears to con-
tribute to the cardiovascular phenotype in a risk factor–
dependent manner (29). If applicable in humans, the
concept of prenatal resetting of vascular functions by
maternal nutrition and particularly by maternal diabetes
would certainly open new epidemiologic and therapeutic
perspectives.
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